We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Evolutec Grp | LSE:EVC | London | Ordinary Share | GB00B01JLR99 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 41.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMNANO
Nanoco Group PLC
08 August 2016
For immediate release 8 August 2016
RNS REACH
NANOCO GROUP PLC
("Nanoco" or the "Company")
Nanoco to Present at Canaccord Genuity's 36th Annual Growth Conference
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that it will be presenting at Canaccord Genuity's 36th Annual Growth Conference on Wednesday 10 August 2016 at 2.00pm EDT. The conference will take place at the Intercontinental Hotel in Boston, Massachusetts.
Michael Edelman, Nanoco's CEO, will provide an overview of Nanoco's cadmium-free quantum dot technology and the exciting progress the Company has made towards commercialisation. The presentation will be followed by a question and answer session.
For further information, please contact:
Nanoco Tel: +44 (0) 161 603 7900 Michael Edelman, Chief Executive Officer David Blain, Chief Financial Officer Tel: + 44 (0) 7799 897357 Caroline Watson, Investor Relations Manager cwatson@nanocotechnologies.com Canaccord Genuity - Joint Tel: +44 (0) 20 7523 8000 Broker Simon Bridges Cameron Duncan Richard Andrews Liberum - Joint Broker Tel: +44 (0) 20 3100 2000 Neil Patel Richard Bootle Steven Tredget Buchanan Tel: +44 (0) 20 7466 5000 Mark Court / Sophie Cowles / Stephanie Watson
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LC displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit:www.nanocogroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRADMGGRVKLGVZM
(END) Dow Jones Newswires
August 08, 2016 02:00 ET (06:00 GMT)
1 Year Evolutec Chart |
1 Month Evolutec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
